Akebia Therapeutics (AKBA) Institutional Ownership $3.19 0.00 (0.00%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$3.20 +0.02 (+0.47%) As of 08/22/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Akebia Therapeutics (NASDAQ:AKBA)CurrentInstitutional OwnershipPercentage33.92%Number ofInstitutional Buyers(last 12 months)92TotalInstitutional Inflows(last 12 months)$85.68MNumber ofInstitutional Sellers(last 12 months)14TotalInstitutional Outflows(last 12 months)$3.85M Get AKBA Insider Trade Alerts Want to know when executives and insiders are buying or selling Akebia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AKBA Institutional Buying and Selling by Quarter Akebia Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Tower Research Capital LLC TRC 22,822$83K0.0%+263.0%0.009% 8/15/2025 E Fund Management Co. Ltd.28,273$103K0.0%+46.4%0.011% 8/15/2025 Rafferty Asset Management LLC253,954$924K0.0%+22.9%0.096% 8/15/2025 Man Group plc41,711$152K0.0%N/A0.016% 8/15/2025 Lazard Asset Management LLC116,485$424K0.0%N/A0.044% 8/15/2025 BNP Paribas Financial Markets520,629$1.90M0.0%+989.8%0.196% 8/15/2025 Brevan Howard Capital Management LP17,148$62K0.0%N/A0.006% 8/15/2025 Bank of America Corp DE1,110,480$4.04M0.0%+130.4%0.419% 8/15/2025 Ameriprise Financial Inc.176,948$644K0.0%+1,368.2%0.067% 8/14/2025 MPM Bioimpact LLC2,889,125$10.52M1.8%N/A1.090% Get the Latest News and Ratings for AKBA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akebia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 Raymond James Financial Inc.59,502$217K0.0%+16.8%0.022% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.149,392$544K0.0%+8.3%0.056% 8/14/2025 The Manufacturers Life Insurance Company 89,677$326K0.0%+21.5%0.034% 8/14/2025 Sei Investments Co.191,245$696K0.0%+9.3%0.072% 8/14/2025 Qube Research & Technologies Ltd1,714,544$6.24M0.0%+60.5%0.647% 8/14/2025 Federated Hermes Inc.617,318$2.25M0.0%-32.4%0.233% 8/13/2025 Affinity Asset Advisors LLC1,950,000$7.10M1.0%+30.0%0.735% 8/13/2025 Diametric Capital LP57,532$209K0.1%-72.8%0.022% 8/13/2025 Walleye Capital LLC214,817$782K0.0%N/A0.081% 8/13/2025 Invesco Ltd.382,210$1.39M0.0%+46.7%0.144% 8/13/2025 OMERS ADMINISTRATION Corp123,700$450K0.0%N/A0.047% 8/13/2025 Panagora Asset Management Inc.210,205$765K0.0%N/A0.079% 8/13/2025 New York State Common Retirement Fund79,100$288K0.0%+106.0%0.030% 8/13/2025 Quadrature Capital Ltd81,944$297K0.0%+200.7%0.031% 8/13/2025 Russell Investments Group Ltd.98,823$360K0.0%-8.6%0.037% 8/12/2025 XTX Topco Ltd150,901$549K0.0%+228.0%0.057% 8/12/2025 Ameritas Investment Partners Inc.25,525$93K0.0%+25.2%0.010% 8/12/2025 Prudential Financial Inc.415,143$1.51M0.0%+542.2%0.157% 8/12/2025 American Century Companies Inc.89,937$327K0.0%N/A0.034% 8/12/2025 Rhumbline Advisers365,035$1.33M0.0%+29.4%0.138% 8/12/2025 Legal & General Group Plc23,279$85K0.0%+26.0%0.009% 8/12/2025 JPMorgan Chase & Co.1,652,746$6.02M0.0%+123.0%0.623% 8/8/2025 Intech Investment Management LLC142,928$520K0.0%+12.2%0.054% 8/8/2025 Creative Planning283,330$1.03M0.0%+23.4%0.108% 8/8/2025 Police & Firemen s Retirement System of New Jersey54,926$200K0.0%+31.3%0.021% 8/8/2025 Geode Capital Management LLC6,074,458$22.12M0.0%+20.7%2.313% 8/7/2025 ProShare Advisors LLC51,266$187K0.0%+9.4%0.020% 8/7/2025 Profund Advisors LLC55,062$200K0.0%+22.6%0.021% 8/7/2025 Acadian Asset Management LLC1,350,185$4.91M0.0%N/A0.514% 8/7/2025 Connor Clark & Lunn Investment Management Ltd.1,180,759$4.30M0.0%+21.7%0.450% One stock to replace Nvidia (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here.8/6/2025 Savant Capital LLC18,967$69K0.0%N/A0.007% 8/1/2025 Y Intercept Hong Kong Ltd30,657$112K0.0%N/A0.012% 7/30/2025 Ethic Inc.40,538$148K0.0%+243.8%0.015% 7/25/2025 CWM LLC22,633$82K0.0%+540.6%0.009% 7/24/2025 PDS Planning Inc50,000$182K0.0%+11.1%0.019% 7/23/2025 Abel Hall LLC10,618$39K0.0%N/A0.004% 7/15/2025 Public Employees Retirement System of Ohio27,200$99K0.0%N/A0.010% 7/10/2025 Wealth Enhancement Advisory Services LLC16,184$59K0.0%N/A0.006% 6/27/2025 Goldman Sachs Group Inc.2,724,439$5.23M0.0%+171.8%1.037% 6/18/2025 Voya Investment Management LLC56,610$109K0.0%-11.3%0.022% 5/29/2025 Rhumbline Advisers282,066$542K0.0%+6.3%0.107% 5/16/2025 Woodline Partners LP2,485,578$4.77M0.0%N/A0.949% 5/16/2025 Exome Asset Management LLC189,087$363K0.3%-8.2%0.072% 5/16/2025 Goldman Sachs Group Inc.2,724,439$5.23M0.0%+171.8%1.041% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.137,897$265K0.0%+9.1%0.053% 5/16/2025 Jacobs Levy Equity Management Inc.1,579,355$3.03M0.0%+28.5%0.603% 5/16/2025 AQR Capital Management LLC176,961$340K0.0%+13.1%0.068% 5/16/2025 Alyeska Investment Group L.P.134,277$258K0.0%N/A0.051% 5/15/2025 Nantahala Capital Management LLC2,000,000$3.84M0.2%N/A0.764% 5/15/2025 Baird Financial Group Inc.21,393$41K0.0%+23.0%0.008% 5/15/2025 State of Wyoming59,206$114K0.0%N/A0.023% 5/14/2025 Affinity Asset Advisors LLC1,500,000$2.88M0.3%N/A0.573% 5/14/2025 Rafferty Asset Management LLC206,630$397K0.0%+15.0%0.079% 5/14/2025 MetLife Investment Management LLC118,164$227K0.0%+13.6%0.045% 5/14/2025 Monashee Investment Management LLC1,500,000$2.88M0.3%N/A0.573% 5/14/2025 Maven Securities LTD200,000$384K0.0%N/A0.076% 5/14/2025 Wellington Management Group LLP666,567$1.28M0.0%+32.7%0.255% 5/13/2025 Sei Investments Co.175,045$336K0.0%N/A0.067% 5/13/2025 E Fund Management Co. Ltd.19,311$37K0.0%+51.9%0.007% 5/13/2025 Informed Momentum Co LLC1,777,911$3.41M0.6%N/A0.679% 5/13/2025 HighTower Advisors LLC126,100$242K0.0%+35.1%0.048% 5/12/2025 Invesco Ltd.260,603$500K0.0%+116.0%0.100% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.969,834$1.86M0.0%-5.6%0.370% 5/9/2025 Deutsche Bank AG161,117$309K0.0%-11.0%0.062% 5/9/2025 Charles Schwab Investment Management Inc.622,914$1.20M0.0%+6.2%0.238% 5/9/2025 Vanguard Group Inc.12,685,803$24.36M0.0%+16.6%4.846% 5/8/2025 XTX Topco Ltd46,011$88K0.0%N/A0.018% 5/7/2025 Mackenzie Financial Corp237,558$456K0.0%+75.5%0.091% 5/6/2025 AIGH Capital Management LLC2,925,000$5.62M2.3%N/A1.117% 5/1/2025 New York State Common Retirement Fund38,400$74K0.0%+207.2%0.016% 4/25/2025 Unified Investment Management17,000$33K0.0%+47.8%0.007% 4/24/2025 PDS Planning Inc45,000$86K0.0%+200.0%0.019% 4/8/2025 Rhumbline Advisers282,066$542K0.0%+6.3%0.119% 3/24/2025 Wellington Management Group LLP502,127$954K0.0%+24.1%0.213% 2/20/2025 Mackenzie Financial Corp135,392$257K0.0%+930.4%0.062% 2/17/2025 Two Sigma Advisers LP143,149$272K0.0%-23.8%0.066% 2/17/2025 Rafferty Asset Management LLC179,752$342K0.0%N/A0.082% 2/17/2025 ProShare Advisors LLC58,585$111K0.0%+49.0%0.027% 2/17/2025 Millennium Management LLC169,647$322K0.0%+738.0%0.078% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.126,380$240K0.0%+10.7%0.058% One stock to replace Nvidia (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here.2/17/2025 Jacobs Levy Equity Management Inc.1,228,710$2.34M0.0%-39.6%0.563% 2/17/2025 Deutsche Bank AG181,048$344K0.0%+64.0%0.083% 2/17/2025 Balyasny Asset Management L.P.274,452$521K0.0%N/A0.126% 2/17/2025 Bank of America Corp DE543,916$1.03M0.0%+117.9%0.249% 2/17/2025 BNP Paribas Financial Markets34,599$66K0.0%-25.2%0.016% 2/14/2025 Jane Street Group LLC202,275$384K0.0%+63.5%0.093% 2/14/2025 Northern Trust Corp1,685,641$3.20M0.0%+3.1%0.773% 2/14/2025 Aquatic Capital Management LLC24,998$47K0.0%N/A0.011% 2/14/2025 Two Sigma Securities LLC40,826$78K0.0%+206.8%0.019% 2/14/2025 Voya Investment Management LLC63,842$121K0.0%-9.3%0.029% (Data available from 1/1/2016 forward) AKBA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AKBA shares? During the previous two years, 113 institutional investors and hedge funds held shares of Akebia Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($24.36M), Geode Capital Management LLC ($22.12M), MPM Bioimpact LLC ($10.52M), Renaissance Technologies LLC ($7.27M), Affinity Asset Advisors LLC ($7.10M), Qube Research & Technologies Ltd ($6.24M), and JPMorgan Chase & Co. ($6.02M).Learn more on Akebia Therapeutics' institutional investors. What percentage of Akebia Therapeutics' stock is owned by institutional investors? 33.92% of Akebia Therapeutics' stock is owned by institutional investors. Learn more on AKBA's institutional investor holdings. Which institutional investors have been buying Akebia Therapeutics' stock? Of the 104 institutional investors that purchased Akebia Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Goldman Sachs Group Inc. ($3.44M), Vanguard Group Inc. ($3.23M), AIGH Capital Management LLC ($2.93M), MPM Bioimpact LLC ($2.89M), Woodline Partners LP ($2.49M), Nantahala Capital Management LLC ($2M), and Affinity Asset Advisors LLC ($1.95M). How much institutional buying is happening at Akebia Therapeutics? Institutional investors have bought a total of 35,792,994 shares in the last 24 months. This purchase volume represents approximately $85.68M in transactions. Which of Akebia Therapeutics' major shareholders have been selling company stock? Of the 14 institutional investors that sold Akebia Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Jacobs Levy Equity Management Inc. ($866.02K), Federated Hermes Inc. ($296.13K), Diametric Capital LP ($153.79K), Connor Clark & Lunn Investment Management Ltd. ($76.86K), Russell Investments Group Ltd. ($68.77K), Two Sigma Advisers LP ($44.70K), and Empirical Asset Management LLC ($20.40K). How much institutional selling is happening at Akebia Therapeutics? Institutional investors have sold a total of 1,636,205 shares in the last 24 months. This volume of shares sold represents approximately $3.85M in transactions. Related Companies KYMR Major Shareholders SRRK Major Shareholders BHC Major Shareholders XENE Major Shareholders AMRX Major Shareholders HCM Major Shareholders RARE Major Shareholders NAMS Major Shareholders MOR Major Shareholders CRNX Major Shareholders This page (NASDAQ:AKBA) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akebia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akebia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access